-
VALUE ASSESSMENT OF BIOLOGIC THERAPIES FOR CROHN'S DISEASE IN CHINA: A RAPID HEALTH TECHNOLOGY ASSESSMENT
Aug 11, 2026, 17:16 PM -
ASSESSMENT OF THE CORRELATION BETWEEN A PRICE LINKAGE POLICY AND PRICE DECLINES FOR OFF-PATENT BIOLOGICS AND BIOSIMILARS AFTER BIOSIMILAR MARKET ENTRY IN 48 MARKETS
Aug 11, 2026, 17:16 PM -
STRUCTURING VALUE ELEMENTS FOR COST-EFFECTIVENESS MODELING: THE STEPPS FRAMEWORK APPLIED TO FAZIRSIRAN IN ALPHA-1 ANTITRYPSIN DEFICIENCY-ASSOCIATED LIVER DISEASE
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF FINERENONE FOR CHINESE PATIENTS WITH HEART FAILURE AND LEFT VENTRICULAR EJECTION FRACTION (LVEF) =40%
Aug 11, 2026, 17:16 PM -
INCREASED RATES OF EMERGENCY CARE IN PEOPLE WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: A POPULATION-BASED COHORT IN ENGLAND 2002 TO 2021
Aug 11, 2026, 17:16 PM -
A MODEL EXPLAINER AGENT TO REDUCE THE COMPREHENSION BURDEN ON HTA ASSESSORS REVIEWING ECONOMIC MODEL SUBMISSIONS: A CASE STUDY IN RARE DISEASE
Aug 11, 2026, 17:16 PM -
A FACTUAL CHECK THAT CANNOT REACH THE REASONING: THE FACTUAL-ACCURACY PARADOX
Aug 11, 2026, 17:16 PM -
EMERGING TRENDS IN HEALTH TECHNOLOGY ASSESSMENT, PRICING, AND REIMBURSEMENT: A STRUCTURED REVIEW OF 2025-2026 GLOBAL POLICY DEVELOPMENTS
Aug 11, 2026, 17:16 PM -
THE PATIENT JOURNEY IN PULMONARY FIBROSIS IN GREECE: DIAGNOSTIC PATHWAYS, DELAYS, AND EARLY MANAGEMENT
Aug 11, 2026, 17:16 PM -
DOES THE ELIGIBILITY RULE, NOT THE DRUG EFFECT, SET THE AFFORDABLE PRICE? A DIALYSIS-REVEALED COST-UTILITY ANALYSIS OF TOLVAPTAN IN ADPKD
Aug 11, 2026, 17:16 PM -
METHODS FOR MODELING IMMATURE OVERALL SURVIVAL (OS) IN BREAST CANCER (BC) IN NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) TECHNOLOGY APPRAISALS (TAS)
Aug 11, 2026, 17:16 PM -
CHALLENGES IN HEALTH ECONOMIC MODELING OF FEMALE-SPECIFIC HEALTH CONDITIONS
Aug 11, 2026, 17:16 PM -
HOW MUCH RESIDUAL BIAS WOULD OVERTURN A PER-PROTOCOL REAL-WORLD EVIDENCE CONCLUSION?
Aug 11, 2026, 17:16 PM -
DO TRADITIONAL SYSTEMATIC LITERATURE REVIEW (SLR) METHODS MEET THE STANDARDS OF TRANSPARENCY AND INCREASING AI-ASSISTED SCREENING? A CASE STUDY COMPARING INDIVIDUAL VS. HIERARCHICAL POPULATION, INTERVENTION/COMPARATOR, OUTCOMES, STUDY DESIGN (PICOS...
Aug 11, 2026, 17:16 PM -
AUSTRIA'S NATIONAL EHEALTH STRATEGY: A COMPARATIVE POLICY ANALYSIS FOCUSED ON THE PREHABILITATION TO REHABILITATION PATHWAY
Aug 11, 2026, 17:16 PM -
DESCRIPTION AND BURDEN OF PORTAL HYPERTENSION TREATMENTS IN FRANCE: A NATIONAL HOSPITAL DATABASE ANALYSIS
Aug 11, 2026, 17:16 PM -
ACCURACY AND EFFICIENCY OF A HUMAN-IN-THE-LOOP PROMPT-FEEDBACK WORKFLOW FOR ARTIFICIAL INTELLIGENCE-ENABLED EVIDENCE SYNTHESIS: A BILIARY TRACT CANCER SYSTEMATIC LITERATURE REVIEW CASE STUDY
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN OF DIABETES COMPLICATIONS IN ALGERIA: A REAL-WORLD BUDGET IMPACT ANALYSIS
Aug 11, 2026, 17:16 PM -
COST-PER-RESPONSE OF ADVANCED THERAPIES IN SPONDYLOARTHRITIS FROM THE PERSPECTIVE OF THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF FENOFIBRATE FOR REDUCING THE PROGRESSION OF DIABETIC RETINOPATHY IN THAILAND
Aug 11, 2026, 17:16 PM
